Document is current

Current Status of Bruton’s Tyrosine Kinase Inhibitor Development and Use in B-Cell Malignancies

Crossref DOI link: https://doi.org/10.1007/s40266-017-0468-4

Published Online: 2017-05-23

Published Print: 2017-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy